Stocks · Health care · Hospital & Medical Service Plans

CLOVER HEALTH INVESTMENTS, CORP.

CLOV Clue Score51
United States Fiscal year ends December CIK 0001801170 Results filed 4 Nov 2026

What the insiders did Scheduled selling only

Insider
Date
Role
Action
Shares
Price
Amount
Karen Soares
20 Oct 2026
Chief Legal Officer
Sold on a plan
19,275
$4.66
$89.82K
Jamie L. Reynoso
19 Oct 2026
CEO, Medicare Advantage
Sold on a plan
4,066
$4.41
$17.93K
Jamie L. Reynoso
15 Oct 2026
CEO, Medicare Advantage
Sold on a plan
18,273
$4.68
$85.52K
Conrad Wai
15 Oct 2026
CEO, Counterpart Health
Sold on a plan
23,627
$4.68
$110.57K
Joseph Clay Thornton
15 Oct 2026
Interim CFO
Sold on a plan
4,591
$4.68
$21.49K
Karen Soares
15 Oct 2026
Chief Legal Officer
Sold on a plan
14,673
$4.68
$68.67K
Andrew Toy
15 Oct 2026
Chief Executive Officer
Sold on a plan
62,176
$4.68
$290.98K
Jamie L. Reynoso
7 Oct 2026
CEO, Medicare Advantage
Sold on a plan
2,006
$4.63
$9.29K

What was left out

Form 4 filings counted 10
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 8
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 515,350
History held since 11 Jan 2021